Reduced Opioid Use Among Patients Who Received Liposomal Bupivacaine for ACL Reconstruction
العنوان: | Reduced Opioid Use Among Patients Who Received Liposomal Bupivacaine for ACL Reconstruction |
---|---|
المؤلفون: | Henry T. Shu, Blake M. Bodendorfer, Paulina M. Szakiel, Brandon T. Stryder, Stephen Luck, Evan H. Argintar, Michael P. Kelly |
المصدر: | Orthopedics. 44 |
بيانات النشر: | SLACK, Inc., 2021. |
سنة النشر: | 2021 |
مصطلحات موضوعية: | Adult, Male, Anterior cruciate ligament reconstruction, medicine.medical_treatment, Young Adult, 03 medical and health sciences, 0302 clinical medicine, medicine, Humans, Pain Management, Orthopedics and Sports Medicine, 030212 general & internal medicine, Medical prescription, Pain, Postoperative, 030222 orthopedics, Anterior Cruciate Ligament Reconstruction, business.industry, Absolute risk reduction, Middle Aged, Liposomal Bupivacaine, Bupivacaine, Analgesics, Opioid, Regimen, Opioid, Anesthesia, Liposomes, Number needed to treat, Surgery, business, Oxycodone, medicine.drug |
الوصف: | Standard multimodal pain management for anterior cruciate ligament reconstruction typically includes a combination of local anesthetics, nonsteroidal anti-inflammatory drugs, and opioids. Opioids present a substantial risk, and there is a rising number of prescription opioid-related overdoses in the United States. The goal of this study was to evaluate the quantity of opioids prescribed to patients who received liposomal bupivacaine as a component of their multi-modal pain regimen. The electronic medical records of patients who underwent anterior cruciate ligament reconstruction by a single surgeon at an urban hospital during a 2-year period were evaluated. Patients in the case group received liposomal bupivacaine and those in the control group did not. Statistical analysis of the number of pills prescribed and numeric pain rating scale scores was performed with a 2-tailed unequal variance t test. Statistical analysis of opioid prescription refills was performed with a chi-square test. A total of 67 patients were included. The mean number of 5-mg oxycodone tablets prescribed to the case group (9.29±10.29 tablets) was significantly lower ( P P P =.09). Patients who received liposomal bupivacaine as part of multimodal pain management had significantly fewer opioid prescriptions. Despite the reduction in opioids prescribed, patients in the case group only showed a trend toward a reduction in pain at 2-week follow-up. [ Orthopedics . 2021;44(2):e229–e235.] |
تدمد: | 1938-2367 0147-7447 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e26c4f0786a7db9f437cf28517edfbd8 https://doi.org/10.3928/01477447-20210104-03 |
رقم الأكسشن: | edsair.doi.dedup.....e26c4f0786a7db9f437cf28517edfbd8 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 19382367 01477447 |
---|